Skip to main content

Table 1 Clinical and molecular characteristics of male patients and female mutation carriers referred for methylation study

From: Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C

Sample ID

Sex

Age (years)

Disease status

Mutation

Cohort

3694a

M

28

Patient

c.4439_4440delAG; p.R1481GfsX9

Discovery/training

3695a

M

26

Patient

c.4439_4440delAG; p.R1481GfsX9

Discovery/training

3696a

F

51

Carrier

c.4439_4440delAG; p.R1481GfsX9

Training

12551D

F

55

Carrier

c.229G>A; p.A77T

Training

cms6013

M

37

Patient

c.229G>A; p.A77T

Testing

cms13123A

F

66

Carrier

c.229G>A; p.A77T

Testing

cms13755

M

13

Patient

c.229G>A; p.A77T

Discovery/training

cms13756

F

17

Carrier

c.229G>A; p.A77T

Testing

cms13757

F

39

Carrier

c.229G>A; p.A77T

Training

cms1179

F

54

Carrier

c.1510G>A; p.V504M

Training

cms1180

M

30

Patient

c.1510G>A; p.V504M

Discovery/training

cms1181

M

26

Patient

c.1510G>A; p.V504M

Testing

cms1224

F

54

Carrier

c.1510G>A; p.V504M

Training

cms1242

M

8

Patient

c.1510G>A; p.V504M

Discovery/training

cms1243

F

31

Carrier

c.1510G>A; p.V504M

Training

cms13185

M

2

Patient

c.1439C>T; p.P480L

Discovery/training

cms13186

M

6

Patient

c.1439C>T; p.P480L

Testing

cms4919B

M

42

Patient

c.1583+5G>A; p.E468GfsX2

Discovery/training

  1. fs frameshift